These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18294567)

  • 1. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 2. Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention.
    Rubboli A; Colletta M; Herzfeld J; Sangiorgio P; Di Pasquale G
    Coron Artery Dis; 2007 May; 18(3):193-9. PubMed ID: 17429293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
    Lip GY
    Am J Med; 2007 Nov; 120(11):920-2. PubMed ID: 17976413
    [No Abstract]   [Full Text] [Related]  

  • 4. Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents.
    Paikin JS; Wright DS; Crowther MA; Mehta SR; Eikelboom JW
    Circulation; 2010 May; 121(18):2067-70. PubMed ID: 20458022
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 6. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risks in atrial fibrillation and simultaneous renal failure].
    Habich S
    Dtsch Med Wochenschr; 2012 Sep; 137(38):1840. PubMed ID: 23133847
    [No Abstract]   [Full Text] [Related]  

  • 9. Balancing risk in atrial fibrillation.
    Ali SN; Hardman SM
    Practitioner; 2001 May; 245(1622):357. PubMed ID: 11373966
    [No Abstract]   [Full Text] [Related]  

  • 10. Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
    Watson T; Lip GY
    Int J Clin Pract; 2006 Mar; 60(3):252-5. PubMed ID: 16494636
    [No Abstract]   [Full Text] [Related]  

  • 11. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
    Sambola A; García-Dorado D
    Coron Artery Dis; 2015 Aug; 26(5):367-8. PubMed ID: 25955251
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes.
    Depta JP; Cannon CP; Fonarow GC; Zhao X; Peacock WF; Bhatt DL;
    Am J Cardiol; 2009 Nov; 104(9):1171-8. PubMed ID: 19840557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithrombotic treatment in atrial fibrillation.
    Lip GY; Boos CJ
    Postgrad Med J; 2008 May; 84(991):252-8. PubMed ID: 18508982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.
    Wellman M; Martin AC
    J Fam Pract; 1999 Jul; 48(7):498. PubMed ID: 10428244
    [No Abstract]   [Full Text] [Related]  

  • 17. Triple antithrombotic therapy in patients with atrial fibrillation undergoing PCI: current evidence and practice.
    Clarke A; Ibrahim A; Kiernan TJ
    Expert Rev Cardiovasc Ther; 2018 Oct; 16(10):715-723. PubMed ID: 30213212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thromboembolic complications in the course of non-valvular atrial fibrillation].
    Mas JL
    Rev Prat; 1995 Apr; 45(8):935-41. PubMed ID: 7761775
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention.
    Bajorek BV; Krass I; Ogle SJ; Duguid MJ; Shenfield GM
    J Am Geriatr Soc; 2005 Nov; 53(11):1912-20. PubMed ID: 16274372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The assessment of the thromboembolic risk and the role of antithrombotic prophylaxis in nonrheumatic atrial fibrillation].
    Fera MS; Giovannini E
    G Ital Cardiol; 1999 Feb; 29(2):193-213. PubMed ID: 10088078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.